Anti-NMDA receptor encephalitis in Japan

Long-term outcome without tumor removal

T. Iizuka, F. Sakai, T. Ide, T. Monzen, S. Yoshii, M. Iigaya, K. Suzuki, D. R. Lynch, N. Suzuki, T. Hata, J. Dalmau

Research output: Contribution to journalArticle

374 Citations (Scopus)

Abstract

OBJECTIVE: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic encephalitis" of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection. METHODS: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present. RESULTS: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically). CONCLUSION: 1) These findings indicate that "juvenile acute nonherpetic encephalitis" or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients' clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.

Original languageEnglish
Pages (from-to)504-511
Number of pages8
JournalNeurology
Volume70
Issue number7
DOIs
Publication statusPublished - 2008 Feb

Fingerprint

Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Japan
Dyskinesias
Encephalitis
Neoplasms
N-Methyl-D-Aspartate Receptors
Antibodies
Prodromal Symptoms
Hypoventilation
Leukocytosis
Recovery of Function
Serum
Amputation
Artificial Respiration
Psychotic Disorders
Immunotherapy
Cognition
Leg
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., ... Dalmau, J. (2008). Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology, 70(7), 504-511. https://doi.org/10.1212/01.wnl.0000278388.90370.c3

Anti-NMDA receptor encephalitis in Japan : Long-term outcome without tumor removal. / Iizuka, T.; Sakai, F.; Ide, T.; Monzen, T.; Yoshii, S.; Iigaya, M.; Suzuki, K.; Lynch, D. R.; Suzuki, N.; Hata, T.; Dalmau, J.

In: Neurology, Vol. 70, No. 7, 02.2008, p. 504-511.

Research output: Contribution to journalArticle

Iizuka, T, Sakai, F, Ide, T, Monzen, T, Yoshii, S, Iigaya, M, Suzuki, K, Lynch, DR, Suzuki, N, Hata, T & Dalmau, J 2008, 'Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal', Neurology, vol. 70, no. 7, pp. 504-511. https://doi.org/10.1212/01.wnl.0000278388.90370.c3
Iizuka, T. ; Sakai, F. ; Ide, T. ; Monzen, T. ; Yoshii, S. ; Iigaya, M. ; Suzuki, K. ; Lynch, D. R. ; Suzuki, N. ; Hata, T. ; Dalmau, J. / Anti-NMDA receptor encephalitis in Japan : Long-term outcome without tumor removal. In: Neurology. 2008 ; Vol. 70, No. 7. pp. 504-511.
@article{ba4148068db14633acd0db9616cd5290,
title = "Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal",
abstract = "OBJECTIVE: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with {"}juvenile acute nonherpetic encephalitis{"} of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection. METHODS: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present. RESULTS: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically). CONCLUSION: 1) These findings indicate that {"}juvenile acute nonherpetic encephalitis{"} or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients' clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.",
author = "T. Iizuka and F. Sakai and T. Ide and T. Monzen and S. Yoshii and M. Iigaya and K. Suzuki and Lynch, {D. R.} and N. Suzuki and T. Hata and J. Dalmau",
year = "2008",
month = "2",
doi = "10.1212/01.wnl.0000278388.90370.c3",
language = "English",
volume = "70",
pages = "504--511",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Anti-NMDA receptor encephalitis in Japan

T2 - Long-term outcome without tumor removal

AU - Iizuka, T.

AU - Sakai, F.

AU - Ide, T.

AU - Monzen, T.

AU - Yoshii, S.

AU - Iigaya, M.

AU - Suzuki, K.

AU - Lynch, D. R.

AU - Suzuki, N.

AU - Hata, T.

AU - Dalmau, J.

PY - 2008/2

Y1 - 2008/2

N2 - OBJECTIVE: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic encephalitis" of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection. METHODS: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present. RESULTS: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically). CONCLUSION: 1) These findings indicate that "juvenile acute nonherpetic encephalitis" or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients' clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.

AB - OBJECTIVE: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic encephalitis" of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection. METHODS: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present. RESULTS: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically). CONCLUSION: 1) These findings indicate that "juvenile acute nonherpetic encephalitis" or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients' clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.

UR - http://www.scopus.com/inward/record.url?scp=40349096525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40349096525&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000278388.90370.c3

DO - 10.1212/01.wnl.0000278388.90370.c3

M3 - Article

VL - 70

SP - 504

EP - 511

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 7

ER -